Inventor · disambiguated record
John Cooke
Also filed as: COOKE JOHN · COOKE JOHN P
49 granted patents·22 pending applications·1,716 citations·filing 1978–2024
99Inventor score
Files withUNIV LELAND STANFORD JUNIOR37VERMILLION INC6BRIGHAM & WOMENS HOSPITAL4COOKE JOHN2COOKE JOHN P2
Top patents by PatentIndex Score
71 records- 0198US5891459AEnhancement of vascular function by modulation of endogenous nitric oxide production or activityUNIV LELAND STANFORD JUNIOR·Filed 1995·Granted Apr 6, 1999·262 cites·22 claims
- 0297US6646006B2Enhancement of vascular function by modulation of endogenous nitric oxide production or activityUNIV LELAND STANFORD JUNIOR·Filed 2002·Granted Nov 11, 2003·66 cites·45 claims
- 0397US5025001AS-nitroso derivatives of ACE inhibitors and the use thereofBRIGHAM & WOMENS HOSPITAL·Filed 1989·Granted Jun 18, 1991·89 cites·22 claims
- 0496US11007210B2Compounds, compositions, methods, and kits relating to telomere extensionUNIV LELAND STANFORD JUNIOR·Filed 2020·Granted May 18, 2021·4 cites·23 claims
- 0595US6642208B2Enhancement of vascular function by modulation of endogenous nitric oxide production or activityUNIV LELAND STANFORD JUNIOR·Filed 2001·Granted Nov 4, 2003·33 cites·21 claims
- 0694US7598275B2Nicotine in therapeutic angiogenesis and vasculogenesisUNIV LELAND STANFORD JUNIOR·Filed 2006·Granted Oct 6, 2009·20 cites·17 claims
- 0794US6417205B1Nicotine in therapeutic angiogenesis and vasculogenesisUNIV LELAND STANFORD JUNIOR·Filed 2000·Granted Jul 9, 2002·80 cites·22 claims
- 0894US5428070ATreatment of vascular degenerative diseases by modulation of endogenous nitric oxide production of activityUNIV LELAND STANFORD JUNIOR·Filed 1993·Granted Jun 27, 1995·226 cites·5 claims
- 0993US6117872AEnhancement of exercise performance by augmenting endogenous nitric oxide production or activityUNIV LELAND STANFORD JUNIOR·Filed 1998·Granted Sep 12, 2000·159 cites·14 claims
- 1092US6063432AArginine or lysine containing fruit healthbar formulationCOOKE PHARMA·Filed 1998·Granted May 16, 2000·111 cites·18 claims
- 1191US9738873B2Activation of innate immunity for enhanced nuclear reprogramming of somatic cells with mRNAUNIV LELAND STANFORD JUNIOR·Filed 2015·Granted Aug 22, 2017·5 cites·9 claims
- 1291US5536723AS-nitroso derivatives of hydrazinoacetic acids, 1-[(acylthio and (mercapto)-1-oxoalkyl]-1,2,34-Tetrahydroquinoline-2-carboxylic acids and alanyl prolines and isoquinolinesBRIGHAM & WOMENS HOSPITAL·Filed 1994·Granted Jul 16, 1996·42 cites·36 claims
- 1390US5945452ATreatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activityUNIV LELAND STANFORD JUNIOR·Filed 1997·Granted Aug 31, 1999·105 cites·10 claims
- 1490US5861168AIntramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injuryUNIV LELAND STANFORD JUNIOR·Filed 1996·Granted Jan 19, 1999·126 cites·8 claims
- 1589US8188043B2Nicotine in therapeutic angiogenesis and vasculogenesisCOOKE JOHN·Filed 2005·Granted May 29, 2012·12 cites·23 claims
- 1688US10760061B2Activation of innate immunity for enhanced nuclear reprogramming of somatic cells with mRNAUNIV LELAND STANFORD JUNIOR·Filed 2017·Granted Sep 1, 2020·3 cites·8 claims
- 1788US7452916B2Enhancement of vascular function by modulation of endogenous nitric oxide production or activityUNIV LELAND STANFORD JUNIOR·Filed 2004·Granted Nov 18, 2008·14 cites·7 claims
- 1886US6720340B1Nicotine receptor agonists in stem cell and progenitor cell recruitmentUNIV LELAND STANFORD JUNIOR·Filed 2000·Granted Apr 13, 2004·36 cites·16 claims
- 1986US5852058AIntramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injuryUNIV LELAND STANFORD JUNIOR·Filed 1996·Granted Dec 22, 1998·65 cites·7 claims
- 2086US5187183AS-nitroso derivatives of ACE inhibitors and the use thereofBRIGHAM & WOMENS HOSPITAL·Filed 1991·Granted Feb 16, 1993·31 cites·21 claims
- 2186US2024277752A1Compounds, compositions, methods, and kits relating to telomere extensionUNIV LELAND STANFORD JUNIOR·Filed 2024·Application pending·0 cites
- 2285US8053204B2Beta-2 microglobulin as a biomarker for peripheral artery diseaseVERMILLION INC·Filed 2010·Granted Nov 8, 2011·4 cites·1 claims
- 2385US7390821B2Methods of reducing angiogenesisUNIV LELAND STANFORD JUNIOR·Filed 2006·Granted Jun 24, 2008·7 cites·49 claims
- 2485US6605115B1Method and composition for inhibiting cardiovascular cell proliferationUNIV LELAND STANFORD JUNIOR·Filed 2000·Granted Aug 12, 2003·58 cites·28 claims
- 2585US6358699B1Assay for asymmetrical NG, NG dimethyl-l-arginineCOOKE PHARMA·Filed 2000·Granted Mar 19, 2002·20 cites·8 claims
- 2685US5356890AS-nitroso derivatives of ace inhibitors and the use thereofBRIGHAM & WOMENS HOSPITAL·Filed 1993·Granted Oct 18, 1994·24 cites·15 claims
- 2783US7045534B2Methods of reducing angiogenesisUNIV LELAND STANFORD JUNIOR·Filed 2003·Granted May 16, 2006·16 cites·14 claims
- 2882US11872243B2Compounds, compositions, methods, and kits relating to telomere extensionUNIV LELAND STANFORD JUNIOR·Filed 2020·Granted Jan 16, 2024·1 cites·28 claims
- 2981US8377646B2Beta-2 microglobulin as a biomarker for peripheral artery diseaseVERMILLION INC·Filed 2011·Granted Feb 19, 2013·2 cites·3 claims
- 3081US7652038B2Methods of reducing angiogenesisUNIV LELAND STANFORD JUNIOR·Filed 2008·Granted Jan 26, 2010·4 cites·36 claims
- 3179US7867719B2Beta-2 microglobulin as a biomarker for peripheral artery diseaseVERMILLION INC·Filed 2007·Granted Jan 11, 2011·4 cites·19 claims
- 3278US6337321B1Enhancement of vascular function by modulation of endogenous nitric oxide production or activityUNIV LELAND STANFORD JUNIOR·Filed 1998·Granted Jan 8, 2002·25 cites·8 claims
- 3377US10525075B2Compounds, compositions, methods, and kits relating to telomere extensionUNIV LELAND STANFORD JUNIOR·Filed 2014·Granted Jan 7, 2020·2 cites·29 claims
- 3475US10264974B2High resolution imaging using near-infrared-II fluorescenceUNIV LELAND STANFORD JUNIOR·Filed 2012·Granted Apr 23, 2019·2 cites·13 claims
- 3573US8008020B2Biomarkers for peripheral artery diseaseVERMILLION INC·Filed 2005·Granted Aug 30, 2011·3 cites·18 claims
- 3672US12053483B2Compounds, compositions, methods, and kits relating to telomere extensionUNIV LELAND STANFORD JUNIOR·Filed 2020·Granted Aug 6, 2024·0 cites·28 claims
- 3772US11884937B2Activation of innate immunity for enhanced nuclear reprogramming of somatic cells with mRNAUNIV LELAND STANFORD JUNIOR·Filed 2020·Granted Jan 30, 2024·0 cites·12 claims
- 3872US7998743B2Panel of biomarkers for peripheral arterial diseaseVERMILLION INC·Filed 2007·Granted Aug 16, 2011·3 cites·11 claims
- 3970US6896339B2Methods and system for controlling latching exhaust valvesGE HARRIS RAILWAY ELECTRONICS·Filed 2003·Granted May 24, 2005·13 cites·28 claims
- 4067US8227201B2BETA2-microglobulin and C reactive protein (CRP) as biomarkers for peripheral artery diseaseCOOKE JOHN P·Filed 2008·Granted Jul 24, 2012·2 cites·11 claims
- 4166US7160904B2Nicotine in therapeutic angiogenesis and vasculogenesisUNIV LELAND STANFORD JUNIOR·Filed 2002·Granted Jan 9, 2007·4 cites·4 claims
- 4265US8236772B2Methods of modulating angiogenesis and screening compounds for activity in modulating angiogenesisCOOKE JOHN P·Filed 2006·Granted Aug 7, 2012·1 cites·5 claims
- 4365US2024316091A1Mcm for gene therapy to activate wnt pathwaySTEADMAN PHILIPPON RES INSTITUTE·Filed 2024·Application pending·0 cites
- 4464US2025114337A1Methods for vascular regeneration and wound treatmentMETHODIST HOSPITAL·Filed 2023·Application pending·0 cites
- 4564US2004082659A1Enhancement of vascular function by modulation of endogenous nitric oxide production or activityUNIV LELAND STANFORD JUNIOR·Filed 2003·Application pending·0 cites
- 4663US2010113353A1Method and composition for inhibiting cardiovascular cell proliferationUNIV LELAND STANFORD JUNIOR·Filed 2009·Application pending·0 cites
- 4762US7611844B2Methods for detecting asymmetric dimethylarginine in a biological sampleUNIV LELAND STANFORD JUNIOR·Filed 2004·Granted Nov 3, 2009·10 cites·16 claims
- 4856US8709735B2β-2 microglobulin as a biomarker for peripheral artery diseaseVERMILLION INC·Filed 2013·Granted Apr 29, 2014·0 cites·11 claims
- 4956US2024149035A1Conductive Biocompatible Scaffold For ElectroporationKADALA ANA ELENA·Filed 2022·Application pending·0 cites
- 5055US2003235573A1Proteins and methods useful for assessing risk of cardiovascular diseaseUNITHER PHARMA INC·Filed 2003·Application pending·0 cites
Showing the top 50 of 71 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →